Sunshine Biopharma Inc. (SBFM): Nasdaq/NYSE listing notice — Sunshine Biopharma receives Nasdaq bid price deficiency notice; 180-day cure period until June 5, 2023

Sunshine Biopharma Inc.

Nasdaq notified SBFM on Dec 6, 2022 that bid price closed below $1.00 for 30 consecutive trading days.
Company must regain compliance by June 5, 2023 by closing at $1.00+ for 10 consecutive business days.
If not compliant by June 5, SBFM may qualify for an additional 180-day extension if it meets other listing standards.
Company says it will monitor bid price and consider options including a reverse stock split.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Sunshine Biopharma Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

December 6, 2022, Sunshine Biopharma, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company no longer meets the minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Marketplace Rule 5550(a)(2), requiring a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”). The notification has no imm

View on SEC.gov

Browse all listing & compliance notices →

Sunshine Biopharma Inc. filing history →

Source: SEC EDGAR

accession 0001683168-22-008309

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.